Immunogenic cell death induced by low temperature plasma to activate antitumor immunity and enhance therapeutic efficiency

被引：2

作者：

Wang, Xiangni ^{[1
,3
]}

Wang, Xiying ^{[1
]}

Liu, Jinren ^{[1
]}

Lu, Jiajia ^{[1
]}

Xu, Guimin ^{[4
]}

Cui, Yixin ^{[1
]}

Shi, Xingmin ^{[1
]}

Zhang, Guanjun ^{[2
]}

机构：

[1] Xi An Jiao Tong Univ, Sch Publ Hlth, Key Lab Dis Prevent & Control & Hlth Promot Shaanx, Hlth Sci Ctr, Xian 710061, Shaanxi, Peoples R China

[2] Xi An Jiao Tong Univ, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Shaanxi, Peoples R China

[3] Yuncheng Vocat & Tech Univ, Yuncheng 044000, Shanxi, Peoples R China

[4] Changan Univ, Sch Energy & Elect Engn, Xian 710000, Shaanxi, Peoples R China

来源：

JOURNAL OF PHYSICS D-APPLIED PHYSICS | 2024年 / 57卷 / 20期

关键词：

low-temperature plasma; immunogenic cell death; tumor microenvironment; cisplatin; immune response; CANCER; COLD; STRESS;

D O I：

10.1088/1361-6463/ad2832

中图分类号：

O59 [应用物理学];

学科分类号：

摘要：

Low-temperature plasma (LTP) has emerged as a groundbreaking method for inducing immunogenic cell death (ICD) in cancer cells. ICD is a form of cellular demise that triggers an immune response against malignant cells. LTP has demonstrated remarkable potential in activating the immune system and augmenting antitumor responses. In this study, we delved into the capacity of LTP to induce ICD and explored its impact on the immune system. Additionally, we assessed the therapeutic effects of LTP-induced ICD on the immune system within a melanoma tumor model. The LTP treated B16F10 (LTP-B16) showed a notable surge in CD8+T cells accompanied by enhanced expression of granzyme B and IFN-gamma, and reduction in Treg cells. This study ingeniously amalgamated LTP-induced ICD with cisplatin to synergistically impede tumor growth. These results offer fresh perspectives for the creation of tumor vaccines based on LTP as well as a new approach for therapeutic tumor immunotherapy.

引用

页数：11

共 44 条

[1] Cancer and the Immune System: The History and Background of Immunotherapy [J].

Abbott, Maura ;

Ustoyev, Yelena .

SEMINARS IN ONCOLOGY NURSING, 2019, 35 (05)

[2] NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019 [J].

Armstrong, Deborah K. ;

Alvarez, Ronald D. ;

Bakkum-Gamez, Jamie N. ;

Barroilhet, Lisa ;

Behbakht, Kian ;

Berchuck, Andrew ;

Berek, Jonathan S. ;

Chen, Lee-may ;

Cristea, Mihaela ;

DeRosa, Marie ;

ElNaggar, Adam C. ;

Gershenson, David M. ;

Gray, Heidi J. ;

Hakam, Ardeshir ;

Jain, Angela ;

Leath, Charles A., III ;

Liu, Joyce ;

Mahdi, Haider ;

Matei, Daniela ;

McHale, Michael ;

McLean, Karen ;

O'Malley, David M. ;

Penson, Richard T. ;

Percac-Lima, Sanja ;

Ratner, Elena ;

Remmenga, Steven W. ;

Sabbatini, Paul ;

Werner, Theresa L. ;

Zsiros, Emese ;

Burns, Jennifer L. ;

Engh, Anita M. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (08) :896-+

[3] Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells [J].

Azzariti, Amalie ;

Iacobazzi, Rosa Maria ;

Di Fonte, Roberta ;

Porcelli, Letizia ;

Gristina, Roberto ;

Favia, Pietro ;

Fracassi, Francesco ;

Trizio, Ilaria ;

Silvestris, Nicola ;

Guida, Gabriella ;

Tommasi, Stefanie ;

Sardella, Eloisa .

SCIENTIFIC REPORTS, 2019, 9 (1)

[4] Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion [J].

Bekeschus, Sander ;

Clemen, Ramona ;

Niessner, Felix ;

Sagwal, Sanjeev Kumar ;

Freund, Eric ;

Schmidt, Anke .

ADVANCED SCIENCE, 2020, 7 (10)

[5] Tumor-induced oxidative stress perturbs nuclear factorr-κB activity-augmenting tumor necrosis factor-α-mediated T-cell death:: Protection by curcumin [J].

Bhattacharyya, Sankar ;

Mandal, Debaprasad ;

Sen, Gouri Sankar ;

Pal, Suman ;

Banerjee, Shuvomoy ;

Lahiry, Lakshmishri ;

Finke, James H. ;

Tannenbaum, Charles S. ;

Das, Tanya ;

Sa, Gaurisankar .

CANCER RESEARCH, 2007, 67 (01) :362-370

[6] Cold Tumors: A Therapeutic Challenge for Immunotherapy [J].

Bonaventura, Paola ;

Shekarian, Tala ;

Alcazer, Vincent ;

Valladeau-Guilemond, Jenny ;

Valsesia-Wittmann, Sandrine ;

Amigorena, Sebastian ;

Caux, Christophe ;

Depil, Stephane .

FRONTIERS IN IMMUNOLOGY, 2019, 10

[7] Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 [J].

Chao, Mark P. ;

Jaiswal, Siddhartha ;

Weissman-Tsukamoto, Rachel ;

Alizadeh, Ash A. ;

Gentles, Andrew J. ;

Volkmer, Jens ;

Weiskopf, Kipp ;

Willingham, Stephen B. ;

Raveh, Tal ;

Park, Christopher Y. ;

Majeti, Ravindra ;

Weissman, Irving L. .

SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (63)

[8] Oncology Meets Immunology: The Cancer-Immunity Cycle [J].

Chen, Daniel S. ;

Mellman, Ira .

IMMUNITY, 2013, 39 (01) :1-10

[9]

Chen J., 2021, Bio Integration, V2, P61, DOI 10.15212/bioi-2021-0007

[10] Turning Cold into Hot: Firing up the Tumor Microenvironment [J].

Duan, Qianqian ;

Zhang, Hualing ;

Zheng, Junnian ;

Zhang, Lianjun .

TRENDS IN CANCER, 2020, 6 (07) :605-618

← 1 2 3 4 5 →